Retinoblastoma
Disease description
Retinoblastoma is a malignant tumor of the retina that commonly affects children under the age of two. Approximately 25% of patients have bilateral hereditary involvement, 15% develop unilateral cancer, and 60% experience unilateral non-hereditary tumors.
The five-year survival rate for patients diagnosed at an early stage is 90%. However, in hereditary retinoblastoma, the recurrence rate doubles.
Symptoms indicating the need for diagnosis and treatment
- Leukocoria (white pupillary reflex) — a white reflection from the retina that appears as a bright spot in the eye
- Strabismus (crossed eyes)
- Visual impairment
- In late stages: orbital tumor, headaches, vomiting
Diagnostic and treatment methods
Diagnostic
- Ultrasound examination
- Computed tomography (CT) or magnetic resonance imaging (MRI)
- Optical coherence tomography (OCT)
- Bone scanning
- Bone marrow biopsy
- Lumbar puncture (collection of cerebrospinal fluid)
Treatment
In advanced unilateral cancer, leading European hospitals use enucleation and chemotherapy. For bilateral tumors, treatment includes photocoagulation, intra-arterial chemotherapy, and cryotherapy. For more on how pediatric oncology differs from adult oncology and which treatment approaches are most effective today, see our article on pediatric oncology.
Innovations in global clinics
World-class medical centers apply molecular genetic testing, conducted in two stages. This analysis identifies the genetic cause of retinoblastoma (detecting damaged DNA) and enables the selection of targeted, etiotropic treatment.
Top Clinics
-
Istanbul, Turkey
Acibadem Altunizade
-
Milan, Italy
San Raffaele University Hospital
-
Vienna, Austria
Confraternität Private Hospital
-
Winterthur, Switzerland
Clinic Lindberg
-
Madrid, Spain
University Clinic HM Madrid
-
Seoul, South Korea
Asan Medical Center
-
Istanbul, Turkey
Istanbul Florence Nightingale Hospital
-
Dubai, UAE
American Hospital Dubai
-
Berlin, Germany
Meoclinic Clinic